PPMD Community

All Blog Posts Tagged 'Staff' (549)


Staff
Update from April 2016 Muscular Dystrophy Coordinating Committee (MDCC) Meeting

It's been a rough few weeks for this community, but our efforts to shape and reshape access barrier issues for our community continue -- and last Wednesday we took a giant leap forward. It was a pivotal day that I was proud to be a part of!



The federal intra-agency…

Continue

Added by Annie Kennedy on May 3, 2016 at 10:28am — 1 Comment


Staff
Changing the Paradigm: The Eteplirsen Ad Comm

There is no way around it, today was hard. Hundreds of us – the largest gathering of Duchenne families in history – came together to tell the FDA that eteplirsen is safe, effective, and should be approved using the tools…

Continue

Added by Pat Furlong on April 25, 2016 at 10:30pm — 5 Comments


Staff
April 25: FDA Advisory Committee Meeting for Eteplirsen - Live Webcast Information

On Monday, April 25, an FDA Advisory Committee will review eteplirsen for potential approval and use within our Duchenne community.

The Duchenne community is joining forces in a show of strength to demonstrate to the FDA our community’s support for our robust therapeutic…

Continue

Added by PPMD on April 21, 2016 at 8:30am — No Comments


Staff
Briefing Documents for Rescheduled Eteplirsen Ad Comm Released

The briefing documents for Sarepta’s Ad Comm on Monday, April 25th have been released. Like you, we…

Continue

Added by PPMD on April 21, 2016 at 8:00am — No Comments


Staff
PPMD Advocates Ensure Congress Recognizes Importance of Flexibility in FDA Reviews

All your calls, emails, and Hill visits during our February Advocacy Conference (in the pouring rain!) are yielding GROUND BREAKING RESULTS.

 …

Continue

Added by PPMD on April 19, 2016 at 4:00pm — No Comments


Staff
PPMD Names Children’s Hospital Los Angeles 10th Certified Duchenne Care Center

PPMD Awards Tenth Clinic Certification as Part of Effort to Ensure People with Duchenne Receive Optimal Care

Children’s Hospital Los Angeles (CHLA) became the tenth clinic named a Certified Duchenne Care Center by…

Continue

Added by PPMD on April 19, 2016 at 9:00am — No Comments


Staff
PPMD’s #EverySingleOne Tour Launched in Baltimore!

On Saturday, Duchenne community members from six states gathered together at the beautiful facilities at Kennedy Krieger in Baltimore – one of PPMD’s Certified Duchenne Care Centers – to hear…

Continue

Added by Annie Kennedy on April 18, 2016 at 12:30pm — No Comments


Staff
Senate Sends Strong Letter to FDA about Duchenne Therapies

Bipartisan Group of Senators Urge FDA to Utilize All Available Tools to Speed Access to Promising Duchenne Therapies

 

On Friday April…

Continue

Added by Ryan Fischer on April 18, 2016 at 9:44am — No Comments


Staff
Parent Project Muscular Dystrophy Convenes Pulmonary Outcomes Workshop



Parent Project Muscular Dystrophy (PPMD) will convene a Pulmonary Outcomes Workshop in Bethesda, Maryland April 14-15. Leading physicians in…

Continue

Added by PPMD on April 14, 2016 at 2:26pm — No Comments


Staff
PPMD’s Patient Preference Study about Pulmonary Outcomes – What we learned and why it matters

Late in 2015, Parent Project Muscular Dystrophy (PPMD) and our research partners at Johns Hopkins Bloomberg School of Public Health (JHSPH) released the results of…

Continue

Added by PPMD on April 13, 2016 at 4:00pm — No Comments


Staff
Catabasis Pharmaceuticals Initiates Part B of the MoveDMD Trial of CAT-1004 for Duchenne

Catabasis announced positive biomarker data from Part A of the MoveDMD trial, as well as initiation of dosing for the first patient for Part B (Phase 2) - a 12-week trial to assess the efficacy of CAT-1004 in Duchenne. We look forward to continued success from our partners at…

Continue

Added by PPMD on April 12, 2016 at 9:30am — No Comments


Staff
PPMD's 2016 Connect Conference Agenda Now Available!

PPMD is excited to unveil the agenda for the 22nd Annual Connect Conference in Orlando, June…

Continue

Added by PPMD on April 11, 2016 at 1:16pm — No Comments


Staff
ACTION ALERT: Please urge Your Senators to Sign Letter to FDA – Applying FDASIA Tools to Duchenne

Earlier this year, 109 members of the House of Representatives sent a powerful letter to the FDA urging them to “utilize all available tools, resources, and authorities” in reviewing a treatment for Duchenne muscular dystrophy. Congressional champions Congressmen Mike Fitzpatrick (R-PA),…

Continue

Added by Ryan Fischer on April 5, 2016 at 11:30am — No Comments


Staff
How You Can Help with the Upcoming Ad Comm for Eteplirsen – Every Single Voice Matters!

We are just a few short weeks from the FDA Advisory Committee Meeting for eteplirsen on April 25th. PPMD is part of a united coalition of Duchenne organizations (MakeDuchenneHistory Coalition) working together to ensure we make the…

Continue

Added by Ryan Fischer on April 4, 2016 at 10:30am — 1 Comment


Staff
Summit Reports Positive Interim Data from New Formulation of SMT C1100 in Duchenne

Summit Therapeutics announced positive interim data from a Phase 1 clinical trial evaluating a new oral formulation of its lead utrophin modulator, SMT…

Continue

Added by PPMD on March 30, 2016 at 9:30am — No Comments


Staff
ReveraGen BioPharma Receives $3M for Phase 2 Studies of Vamorolone in Duchenne

PPMD is thrilled to see the continued progress of VBP-15, now known as Vamorolone. Progress to date includes a first in-human study of healthy volunteers and animal data which suggests it has none of the side…

Continue

Added by PPMD on March 28, 2016 at 2:30pm — 1 Comment


Staff
Update on Gene Replacement/Repair Strategies for Duchenne Muscular Dystrophy

There has been a flurry of press recently on gene therapy in Duchenne muscular dystrophy and CRISPR technology. With this barrage of information, PPMD wanted to take a deeper dive into gene therapy as a potential treatment for Duchenne.

 

An Expert…

Continue

Added by Abby Bronson on March 25, 2016 at 9:30am — No Comments


Staff
PPMD is Initial Partner in OnPAR — Online Partnership to Accelerate Research

The National Institutes of Health (NIH) is one of the biggest funders of medical research in the US, and projects it has funded have touched almost every Duchenne therapeutic in development now in some way. In FY2016, the NIH…

Continue

Added by Abby Bronson on March 24, 2016 at 9:30am — No Comments


Staff
DuchenneConnect & UCLA Recruiting Patients for Genetic Modifiers Study

We know that changes or mutations in the Dystrophin gene are what cause Duchenne and Becker but we don’t have a good understanding of why people within the same family with the same genetic change…

Continue

Added by Ann Martin on March 15, 2016 at 10:49am — No Comments

Monthly Archives

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

© 2016   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service